Priya Sachdeva

Stock Analyst at UBS

(0.21)

# 4,334

Out of 5,002 analysts

5

Total ratings

20%

Success rate

-12.49%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$249.63	+34.20%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$10.14	+67.65%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $249.63

Upside: +34.20%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $10.14

Upside: +67.65%